RecruitingNot ApplicableNCT03704207
Utility of PCD Diagnostics to Improve Clinical Care
Sponsor
Vanderbilt University Medical Center
Enrollment
200 participants
Start Date
Jun 1, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Eligibility
Min Age: 1 Year
Inclusion Criteria3
- Referred to center for PCD diagnosis considerations
- Ability to perform study procedures
- Age greater than 2 years of age
Exclusion Criteria1
- Age less than 2 years of age Inability to perform informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERnNO testing
Collection of already performed clinical data and nNO testing
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03704207
Related Trials
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
NCT072746311 location
DCP (RaDiCo Cohort) (RaDiCo-DCP)
NCT0595147832 locations
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
NCT072888271 location
Living With Primary Ciliary Dyskinesia (Living With PCD)
NCT046024811 location
Swiss Primary Ciliary Dyskinesia Registry
NCT036062001 location